Oura to acquire AI primary care startup Counsel Health for $625 million

The deal

Oura, the company behind the Oura Ring smart ring, has agreed to acquire Counsel Health for $625 million, announcing the deal alongside quarterly earnings on Tuesday. The acquisition lands just weeks after Oura shelved its up to $2.2 billion IPO indefinitely, a move TechCrunch reports was attributed to "uncertainty in the IPO market."

The price is striking given Counsel's size. According to TechCrunch, the startup raised a $25 million Series A about a year ago, led by Andreessen Horowitz and GV, and PitchBook estimates its total funding at roughly $36 million.

The two companies are already intertwined: Counsel's medical AI chatbot was integrated into the Oura app in June, per TechCrunch.

From tracking to treatment

Counsel Health calls itself an "AI-native primary care company." As The Verge describes it, the app delivers AI-generated responses and insights drawn from a user's wearable health data, and users can escalate from there to a conversation with one of Counsel's staff physicians.

Oura CEO Tom Hale told Bloomberg, according to The Verge, that the deal is part of a plan to connect wearables, clinical AI, and access to doctors, so biometric data can be used to answer health questions or monitor ongoing conditions. In a press release quoted by TechCrunch, Hale said Oura helps members understand their physiology, and with Counsel they can act on it "from quick questions and prescriptions to lab results, chronic care, and referrals."

The combined company plans to build across three areas: preventative care, acute care for episodic health concerns, and specialty and chronic care, including reproductive and cardiometabolic health.

What changes at Counsel

Counsel CEO Muthu Alagappan will become Oura's chief clinical AI officer, and Counsel's 70 employees will join Oura, Bloomberg reports. Alagappan also told Bloomberg that Counsel plans to expand its network of on-demand physicians, which currently stands at about 50 people.

Counsel will not be folded entirely into Oura's consumer app. The Verge reports that it will keep offering its medical AI platform to new and existing enterprise partners, including health plans, health systems, consumer health organizations, and employers.

The reported timelines for the deal's completion conflict: The Verge says Oura expects it to close before the end of the year, while TechCrunch reports an expected close before the end of 2027.

The financial backdrop

The acquisition arrives on strong financial footing, judging by the numbers Oura disclosed. TechCrunch reports the company's revenue grew 153 percent year over year to $533 million for the quarter ended September 30, and that fiscal 2026 revenue came in at roughly $1.75 billion, up 92 percent. Oura reached an $11 billion valuation after a $900 million late-stage funding round in October 2025.

TechCrunch also points to competitive pressure: Oura has dominated the smart ring market for years, but rivals such as RingConn and Ultrahuman are emerging, pushing the company to keep expanding beyond the device itself.

Why it matters

The deal is a bet that wearable data becomes far more valuable when paired with care delivery. Oura's rings already collect continuous biometrics; Counsel adds an AI layer that interprets that data and a physician network that can act on it. If it works, Oura stops being a consumer gadget company and becomes a healthcare services platform, with the recurring revenue that implies.

It is also a test case for physician-in-the-loop medical AI at scale. Alagappan emphasized in the press release, via TechCrunch, that Counsel built its AI around trust and safety while keeping doctors involved in clinical decisions, positioning meant to reassure regulators and users as AI chatbots move deeper into diagnosis-adjacent territory.

Finally, the acquisition signals where consolidation is heading. An $11 billion hardware maker spending $625 million on a startup with an estimated $36 million raised shows how quickly AI healthcare companies are being absorbed by the platforms that own the underlying health data.